COVID-19大流行期间肺栓塞的诊断与治疗:国家PERT联盟立场文件
该立场文件由美国国家肺栓塞快速反应团队(PERT)联盟发布,针对COVID-19合并肺栓塞(PE)患者诊治的特殊挑战提出调整建议。文件强调需调整诊断路径、纳入COVID-19的促血栓贡献、管理双重危重心肺疾病,并保护患者与医护人员。基于团队决策(如PERT)的优势在危机中更为明显,同时强调长期随访的重要性。
要点
- COVID-19合并PE需调整既有诊断与治疗流程。
- 应纳入COVID-19的促血栓形成贡献进行综合评估。
- PERT团队决策模式在疫情危机中价值更突出。
核心结论
- COVID-19与PE共存时需对既定诊治流程进行修改,以应对诊断与治疗的双重挑战。
研究设计与样本
- 美国国家PERT联盟发布的立场文件,基于专家共识提出诊治建议。
主要发现
- COVID-19的独特方面会干扰PE的诊断与治疗,需调整诊断模态并纳入其促血栓贡献。
- 需同时管理两种危重心肺疾病,并在提供最佳救治时保护患者与医护人员。
- 团队决策与协调照护(如PERT)的优势在疫情危机中更为明显。
- 对具有长期影响的两种疾病患者应重视仔细的随访照护。
临床怎么用
- 对COVID-19患者疑诊PE时应根据疫情背景调整诊断策略。
- 建议采用PERT等多学科团队模式进行决策与照护协调。
- 诊治过程中需兼顾医护人员防护与患者安全。
- 出院后应安排针对PE及COVID-19长期影响的随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The coexistence of coronavirus disease 2019 (COVID-19) and pulmonary embolism (PE), two life-threatening illnesses, in the same patient presents a unique challenge. Guidelines have delineated how best to diagnose and manage patients with PE. However, the unique aspects of COVID-19 confound both the diagnosis and treatment of PE, and therefore require modification of established algorithms. Important considerations include adjustment of diagnostic modalities, incorporation of the prothrombotic contribution of COVID-19, management of two critical cardiorespiratory illnesses in the same patient, and protecting patients and health-care workers while providing optimal care. The benefits of a team-based approach for decision-making and coordination of care, such as that offered by pulmonary embolism response teams (PERTs), have become more evident in this crisis. The importance of careful follow-up care also is underscored for patients with these two diseases with long-term effects. This position paper from the PERT Consortium specifically addresses issues related to the diagnosis and management of PE in patients with COVID-19.
引用
- Rosovsky RP, Grodzin C, Channick R, et al. Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic: A Position Paper From the National PERT Consortium. Chest. 2020. PMID: 32861692. doi:10.1016/j.chest.2020.08.2064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。